EC
EcoR1 Capital Portfolio holdings
AUM
$1.69B
This Quarter Return
+31.56%
1 Year Return
+7.54%
3 Year Return
+113.08%
5 Year Return
+306.58%
10 Year Return
+4,328.75%
AUM
$3.85B
AUM Growth
+$3.85B
(+31%)
Cap. Flow
+$284M
Cap. Flow
% of AUM
7.37%
Top 10 Holdings %
Top 10 Hldgs %
72.18%
Holding
59
New
10
Increased
9
Reduced
4
Closed
8
Top Buys
| 1 |
argenx
ARGX
|
$115M |
| 2 |
MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
|
$96.9M |
| 3 |
Sarepta Therapeutics
SRPT
|
$80.3M |
| 4 |
Jazz Pharmaceuticals
JAZZ
|
$79.4M |
| 5 |
Arvinas
ARVN
|
$51.8M |
Top Sells
| 1 |
Revolution Medicines
RVMD
|
$156M |
| 2 |
SWTX
SpringWorks Therapeutics
SWTX
|
$80M |
| 3 |
MORF
Morphic Holding, Inc. Common Stock
MORF
|
$36.6M |
| 4 |
Relay Therapeutics
RLAY
|
$35M |
| 5 |
SLRN
ACELYRIN
SLRN
|
$14.3M |
Sector Composition
| 1 | Healthcare | 99.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Apellis Pharmaceuticals
APLS
$3.48B
| $669M | 17.37% | 11,173,068 +273,209 | +3% | +$16.4M |
|
|
MRTX
2
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $435M | 11.28% | 7,396,979 +1,648,580 | +29% | +$96.9M |
|
3
Prothena Corp
PRTA
$441M
| $421M | 10.93% | 11,584,280 | – | – |
|
|
4
Arvinas
ARVN
$568M
| $277M | 7.19% | 6,726,491 +1,259,428 | +23% | +$51.8M |
|
5
Galapagos
GLPG
$2.07B
| $234M | 6.08% | 5,756,268 | – | – |
|
6
Acadia Pharmaceuticals
ACAD
$4.38B
| $188M | 4.87% | 5,991,479 | – | – |
|
7
AnaptysBio
ANAB
$569M
| $161M | 4.18% | 7,521,024 | – | – |
|
8
Zymeworks
ZYME
$1.12B
| $140M | 3.62% | 13,437,473 | – | – |
|
9
Tango Therapeutics
TNGX
$747M
| $132M | 3.43% | 13,330,736 +4,609,100 | +53% | +$45.6M |
|
|
10
Jazz Pharmaceuticals
JAZZ
$7.75B
| $125M | 3.24% | 1,013,952 +645,541 | +175% | +$79.4M |
|
|
11
argenx
ARGX
$43.6B
| $115M | 2.97% | +300,997 | New | +$115M |
|
12
Xencor
XNCR
$580M
| $112M | 2.91% | 5,282,516 | – | – |
|
13
Kura Oncology
KURA
$686M
| $83.5M | 2.17% | 5,806,871 | – | – |
|
|
14
Sarepta Therapeutics
SRPT
$1.78B
| $80.3M | 2.09% | +832,907 | New | +$80.3M |
|
15
Crinetics Pharmaceuticals
CRNX
$2.92B
| $71.6M | 1.86% | 2,012,517 +482,254 | +32% | +$17.2M |
|
16
Mersana Therapeutics
MRSN
$36.5M
| $44.9M | 1.17% | 19,364,688 | – | – |
|
|
CNTA
17
Centessa Pharmaceuticals
CNTA
$2.25B
| $44.7M | 1.16% | 5,618,779 | – | – |
|
18
Immunome
IMNM
$828M
| $41.5M | 1.08% | +3,879,415 | New | +$41.5M |
|
19
Edgewise Therapeutics
EWTX
$1.51B
| $38.2M | 0.99% | 3,493,194 | – | – |
|
20
Neumora Therapeutics
NMRA
$280M
| $35.3M | 0.92% | 2,071,450 | – | – |
|
|
THRD
21
DELISTED
Third Harmonic Bio
THRD
| $34.9M | 0.91% | 3,182,444 +200,000 | +7% | +$2.19M |
|
22
Voyager Therapeutics
VYGR
$186M
| $32.5M | 0.84% | 3,851,507 | – | – |
|
23
Alector
ALEC
$238M
| $32.4M | 0.84% | 4,056,548 | – | – |
|
24
Oric Pharmaceuticals
ORIC
$994M
| $31.4M | 0.82% | 3,418,068 | – | – |
|
25
TScan Therapeutics
TCRX
$102M
| $29.2M | 0.76% | 5,000,000 | – | – |
|